vimarsana.com
Home
Live Updates
FDA Issues Draft Guidance for Obtaining Postmarket Data on U
FDA Issues Draft Guidance for Obtaining Postmarket Data on U
FDA Issues Draft Guidance for Obtaining Postmarket Data on Underrepresented Populations in Drug Clinical Trials | King & Spalding
The Food and Drug Administration (FDA) has issued new draft guidance, Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological...
Related Keywords
United States ,
,
Drug Administration ,
King Spalding ,
Postmarketing Approaches ,
Obtain Data ,
Populations Underrepresented ,
Clinical Trials ,
Draftpostmarketing Approaches Guidance ,
New Drug Applications ,
Diversity Action Plans ,
Biologics License Application ,
Diversity Plans ,
Improve Enrollment ,
Underrepresented Racial ,
Ethnic Populations ,
Consolidated Appropriations Act ,